Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles

被引:15
作者
Gavine, PR
Neil, JC
Crouch, DH [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland
[2] Univ Glasgow, Sch Vet, Dept Vet Pathol, Glasgow G61 1QH, Lanark, Scotland
关键词
Myc; viral mutations; stabilization;
D O I
10.1038/sj.onc.1203102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myc is overexpressed in many cancers as a result of gene rearrangement or amplification, but coding sequence changes which cluster in the N-terminal transactivation domain also appear to play a role in tumour progression. The prototypic v-Myc gene of MC29 virus differs from avian c-Myc by a series of mutations, including a change at a regulatory phosphorylation site within the mutational hotspot (thr-61) which is known to potentiate transformation in vitro. We now show that the mutation at thr-61 stabilizes the v-Myc protein (turnover difference) and that this single mutation is both necessary and sufficient for the phenotype. A major involvement of the proteasome in Myc degradation was confirmed, but surprisingly, a dilysine motif adjacent to thr-61 proved not to be the ubiquitin target. Two other v-Myc genes which carry a mutation at thr-61 (avian MH2) or a large deletion encompassing this domain (feline T17) were found to be stabilized to a similar extent as MC29, showing that stabilization is a common feature of independently derived Myc oncogenes, These results suggest a common selective process in the genesis of these three viral oncoproteins and a mechanistic link with Jun, Fos and Myb oncoproteins which are also stabilized relative to their cellular counterparts.
引用
收藏
页码:7552 / 7558
页数:7
相关论文
共 37 条
[1]   Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway [J].
Bies, J ;
Wolff, L .
ONCOGENE, 1997, 14 (02) :203-212
[2]   A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein [J].
Breitschopf, K ;
Bengal, E ;
Ziv, T ;
Admon, A ;
Ciechanover, A .
EMBO JOURNAL, 1998, 17 (20) :5964-5973
[3]  
Chen RH, 1996, ONCOGENE, V12, P1493
[4]   The ubiquitin-proteasome pathway: on protein death and cell life [J].
Ciechanover, A .
EMBO JOURNAL, 1998, 17 (24) :7151-7160
[5]  
COLL J, 1983, EMBO J, V12, P2189
[6]   The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling [J].
Colman, MS ;
Ostrowski, MC .
NUCLEIC ACIDS RESEARCH, 1996, 24 (10) :1971-1978
[7]  
CROUCH DH, 1990, ONCOGENE, V5, P683
[8]  
CROUCH DH, 1993, ONCOGENE, V8, P1849
[9]  
CURRAN T, 1984, CELL, V36, P259
[10]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731